| Essential Thrombocythemia studied in …STUDIED_INderived93 of 93show fewer |
|---|
| → studied in | NCT06661915Phase 2 · recruiting A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs) · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05025488Phase 1 · active not recruiting Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04282187Phase 2 · recruiting Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01831635completed Myeloproliferative Neoplasms: an In-depth Case-control Study · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02577926Phase 2 · active not recruiting The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06361641NA · recruiting Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04285086Phase 3 · active not recruiting Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03862157Phase 1/Phase 2 · active not recruiting Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03289910Phase 2 · active not recruiting Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02158858Phase 1/Phase 2 · completed A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies · condition mapped ALIAS · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07612280Phase 1/Phase 2 · recruiting Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07590986recruiting Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878199Phase 1/Phase 2 · terminated Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07518940NA · not yet recruiting ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia · condition mapped ALIAS · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06351631Phase 3 · recruiting A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017) · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04279847Phase 1 · active not recruiting Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms · condition mapped ALIAS · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06063486Phase 2 · recruiting Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05198960Phase 3 · recruiting AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05123365Phase 1/Phase 2 · recruiting An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04942080NA · recruiting Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI) · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04645199recruiting National Longitudinal Cohort of Hematological Diseases · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07362225recruiting MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) · condition mapped ALIAS · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644211Phase 2 · recruiting Ruxolitinib in Thrombocythemia and Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04262141Phase 2 · active not recruiting IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV) · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541249Phase 2 · recruiting MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05031897Phase 2 · recruiting Two Step Haplo With Radiation Conditioning · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05223920Phase 2 · completed An Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-7289-CTP-202/MK-3543-005) · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06378437Phase 1 · recruiting A Study of GLB-001 in Patients With Myeloid Malignancies · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482971Phase 2 · active not recruiting A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588991Phase 1 · completed Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06798805active not recruiting Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03869476NA · completed Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms. · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06734637NA · recruiting Efficacy and Safety of Peginterferon in ET and PV. · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02760238recruiting Myeloproliferative Neoplasms (MPNs) Patient Registry · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02897297unknown Myeloproliferative Neoplastic Diseases Observatory From Brest · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04243122Phase 2 · completed Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06218628Phase 1 · recruiting Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition · condition mapped ALIAS · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06371573completed Ultrasound Examination for Spleen Volume Evaluation in Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03972943early Phase 1 · terminated CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01816256NA · completed Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03566446Phase 1 · completed CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04051307Phase 1/Phase 2 · completed Dual Vaccine Trial in Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02124746Phase 2 · completed Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05882773recruiting Asian Myeloproliferative Neoplasm (MPN) Registry · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02556931Phase 2 · completed Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01014546Phase 1 · terminated Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01387763Phase 3 · completed A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00489203Phase 2 · completed Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02912884completed Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03121599NA · terminated 18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02823184completed Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01998828Phase 2 · terminated Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787552Phase 1/Phase 2 · completed A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907436NA · completed The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397813Phase 2 · completed Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089011Phase 2 · completed Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03745378completed Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study) · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02129101Phase 1 · completed Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00715247completed Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02407080Phase 1 · completed Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00666549completed Research Tissue Bank · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02311569Phase 2 · completed Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00718159Phase 1 · completed Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00665067completed Correlative Biomarker Study in Patients With Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02893410completed Drug Observance and Side Effects of Cytoreductive Drugs in PV and ET Patients · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01053494NA · completed Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01134120Phase 1 · completed A Study in Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01970930completed Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) Patients · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445744NA · completed Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00666289completed Familial Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00433862completed Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders · condition mapped ALIAS · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01520220Phase 1 · completed Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052520Phase 1/Phase 2 · completed Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02663648withdrawn Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01243073Phase 2 · completed Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00586651Phase 2 · completed Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis · condition mapped ALIAS · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02076815Phase 3 · completed Anagrelide Retard in Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381550Phase 2 · completed 3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00668421Phase 1/Phase 2 · unknown CEP-701 (Lestaurtinib) in Myelofibrosis · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00227591Phase 2 · completed Lenalidomide and Prednisone in Treating Patients With Myelofibrosis · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039416Phase 2 · completed Imatinib Mesylate in Treating Patients With Myelofibrosis · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047190Phase 2 · completed Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357305Phase 1 · completed Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01816022unknown Myeloproliferative Neoplasms and Bone Structure · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025415Phase 1 · completed Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00745550Phase 1/Phase 2 · completed A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866762Phase 2 · unknown A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00522574Phase 1 · terminated A Safety Study of XL019 in Adults With Myelofibrosis · condition mapped ONTOLOGY_EXACT · 93 trials mapped (31 active) | — | — | Essential Thrombocythemia | 1 | Observed | clinicaltrials | graph → |